The Potential - and Pitfalls - of Biosimilars - Eric Snyder
With a $30B global forecast, biosimilars of market-leading therapeutics are a reality. We discuss their potential and how reimbursement is an obstacle to broad adoption.
The Potential - and Pitfalls - of Biosimilars - Eric Snyder
With a $30B global forecast, biosimilars of market-leading therapeutics are a reality. We discuss their potential and how reimbursement is an obstacle to broad adoption.